Medovate partners with Medipex to support medical device innovations
Medical device company Medovate has partnered with Medipex Healthcare Innovation Hub to support the development of promising new medical device innovations arising from within the NHS.
Medipex – an award-winning healthcare innovation hub which connects the NHS with industry and academia – currently has active engagement with 19 NHS Trusts within the Yorkshire & Humber and East Midlands regions. The company works closely with NHS inventors and innovative clinical groups to develop healthcare innovations that deliver better patient care, improved services and generate cost savings.
Through their new partnership, Medovate and Medipex will provide the foundation and structure for a joint working relationship to support new NHS-created medical device innovations through the full development cycle.
Robert Donald, new business manager at Medovate, said: “We are delighted to be starting this new partnership with Medipex to support the development of inspiring new medical device innovations that can deliver improved patient care. We look forward to building a close relationship with the team as we work towards our joint vision of bringing to life unique innovations from within the NHS.”
Established in 2004, Medipex has a long track record which includes the creation of medical device companies Zilico (founded through a successful collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust), who have developed a revolutionary cancer diagnostics technology; and Organ Preservation Solutions, which is bringing to market next generation products in the field of organ transplantation (founded through Leeds Teaching Hospitals NHS Trust and the University of Leeds).
Dr Lindsay Georgopoulos, CEO of Medipex, added: “Being at the forefront of NHS innovation, we are excited to enter a new partnership with Medovate, who have extensive experience in successfully bringing to global markets pioneering medical devices that can positively impact healthcare and the economy. Through this agreement Medipex is providing a new route to market for promising new innovations created within our NHS member Trusts. We look forward to building a long, successful partnership and working together to help advance innovations in patient care.”
Over the coming years Medovate and Medipex will be working together to foster new technologies sourced by Medipex through their NHS partnerships that can transform patient care, with Medovate working to raise their profile and bring them to a worldwide market.